See more : Skyworks Solutions, Inc. (AWM.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Benitec Biopharma Inc. (BNTC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Benitec Biopharma Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Kadem Sustainable Impact Corporation (KSICU) Income Statement Analysis – Financial Results
- Uniti Group Inc. (0LJB.L) Income Statement Analysis – Financial Results
- Scientech Corporation (3583.TW) Income Statement Analysis – Financial Results
- FB Bancorp, Inc. Common Stock (FBLA) Income Statement Analysis – Financial Results
- Srisawad Corporation Public Company Limited (SAWAD.BK) Income Statement Analysis – Financial Results
Benitec Biopharma Inc. (BNTC)
About Benitec Biopharma Inc.
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 216.00K | 75.00K | 73.00K | 59.00K | 97.00K | 11.32M | 455.45K | 450.31K | 346.51K | 829.13K | 1.02M | 545.73K |
| Cost of Revenue | 108.00K | 381.00K | 9.00K | 123.00K | 268.07K | 426.51K | 331.30K | 209.02K | 103.80K | 30.68K | 37.66K | 176.13K |
| Gross Profit | 108.00K | -306.00K | 64.00K | -64.00K | -171.07K | 10.89M | 124.15K | 241.29K | 242.70K | 798.45K | 980.10K | 369.60K |
| Gross Profit Ratio | 50.00% | -408.00% | 87.67% | -108.47% | -176.36% | 96.23% | 27.26% | 53.58% | 70.04% | 96.30% | 96.30% | 67.73% |
| Research & Development | 15.61M | 12.77M | 11.27M | 7.02M | 3.00M | 2.17M | 5.06M | 5.32M | 9.92M | 4.78M | 5.86M | 3.43M |
| General & Administrative | 6.71M | 6.38M | 6.65M | 6.51M | 5.57M | 6.66M | 6.41M | 6.99M | 8.96M | 6.17M | 7.67M | 4.39M |
| Selling & Marketing | 277.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.99M | 6.38M | 6.65M | 6.51M | 5.57M | 6.66M | 6.41M | 6.99M | 8.96M | 6.17M | 7.67M | 4.39M |
| Other Expenses | -216.00K | -30.00K | -79.00K | 37.00K | -5.00K | 154.77K | 734.59 | -7.91M | -2.68M | -2.14M | -2.18M | -708.18K |
| Operating Expenses | 22.38M | 19.16M | 17.92M | 13.53M | 8.56M | 8.99M | 8.68M | 4.40M | 16.20M | 8.80M | 11.35M | 7.11M |
| Cost & Expenses | 22.49M | 19.16M | 17.93M | 13.66M | 8.38M | 9.41M | 9.01M | 4.61M | 16.31M | 8.84M | 11.38M | 7.28M |
| Interest Income | 0.00 | 49.55K | 46.35K | 0.00 | 62.00K | 119.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 904.00K | 33.00K | 32.00K | 6.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 0.00 | 381.00K | 392.00K | 424.00K | 374.00K | 154.77K | 142.51K | 166.75K | 11.54M | 74.40K | 4.50M | 1.52M |
| EBITDA | -22.49M | -18.70M | -17.85M | -13.60M | -7.91M | 2.74M | -8.59M | -4.19M | -13.42M | -7.93M | -9.90M | -6.64M |
| EBITDA Ratio | -10,412.04% | -24,973.33% | -24,565.75% | -22,506.78% | -8,059.79% | 19.07% | -1,846.62% | -840.79% | -3,872.42% | -857.54% | -972.53% | -1,215.89% |
| Operating Income | -22.49M | -19.08M | -17.85M | -13.60M | -8.28M | 2.00M | -8.55M | -15.92M | -24.96M | -13.33M | -14.40M | -8.16M |
| Operating Income Ratio | -10,412.04% | -25,441.33% | -24,457.53% | -23,044.07% | -8,537.11% | 17.70% | -1,877.75% | -3,536.22% | -7,204.20% | -1,607.59% | -1,414.88% | -1,494.87% |
| Total Other Income/Expenses | 120.00K | -481.00K | -354.00K | -286.00K | 7.00K | 606.03K | 179.24K | 11.55M | 6.46M | 4.50M | 3.56M | 1.32M |
| Income Before Tax | -22.37M | -19.56M | -18.21M | -13.88M | -8.27M | 2.87M | -8.55M | -4.37M | -18.50M | -8.83M | -10.84M | -6.84M |
| Income Before Tax Ratio | -10,356.48% | -26,082.67% | -24,942.47% | -23,528.81% | -8,529.90% | 25.34% | -1,877.42% | -970.99% | -5,340.09% | -1,064.66% | -1,064.66% | -1,253.01% |
| Income Tax Expense | -619.00K | 3.00K | 354.00K | -101.00K | 27.00K | -864.22K | 1.47K | 209.79K | -9.00M | 821.46K | -4.03M | -414.32K |
| Net Income | -21.75M | -19.56M | -18.56M | -13.78M | -8.30M | 2.87M | -8.55M | -4.37M | -18.50M | -8.83M | -10.84M | -6.42M |
| Net Income Ratio | -10,069.91% | -26,082.67% | -25,427.40% | -23,357.63% | -8,557.73% | 25.34% | -1,877.42% | -970.99% | -5,340.09% | -1,064.66% | -1,064.66% | -1,177.09% |
| EPS | -5.36 | -14.12 | -38.62 | -54.54 | -138.19 | 56.89 | -207.21 | -127.11 | -663.12 | -389.77 | -611.08 | -1.45K |
| EPS Diluted | -5.36 | -14.12 | -38.62 | -54.54 | -138.19 | 56.89 | -207.21 | -127.11 | -663.12 | -389.77 | -611.08 | -1.45K |
| Weighted Avg Shares Out | 4.06M | 1.39M | 480.69K | 252.67K | 60.07K | 50.40K | 41.27K | 34.40K | 27.90K | 22.65K | 17.73K | 4.43K |
| Weighted Avg Shares Out (Dil) | 4.06M | 1.39M | 480.69K | 252.67K | 60.07K | 50.40K | 41.27K | 34.40K | 27.90K | 22.65K | 17.73K | 4.43K |
BNTC Stock: One Big Investor Has Benitec Biopharma Shares Going Bonkers
Benitec Biopharma (BNTC) stock is rocketing higher in early morning trading on Tuesday after disclosing a new large stake in the company. The post BNTC Stock: One Big Investor Has Benitec Biopharma Shares Going Bonkers appeared first on InvestorPlace.
BNTC Stock Price Increased Over 80% Pre-Market: Why It Happened
The stock price of Benitec Biopharma Inc (NASDAQ: BNTC) increased by over 80% pre-market. This is why it happened.
Benitec Biopharma Announces 2020 Annual Stockholder Meeting
HAYWARD, Calif., Dec. 7, 2020 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), today announced that its 2020 Annual Meeting of Stockholders will be held virtually on Wednesday December 9, 2020 at 3 p.m. (Pacific Time). The meeting details and instructions...
Comparing BB Liquidating (OTCMKTS:BLIAQ) and Netflix (OTCMKTS:NFLX)
Netflix (NASDAQ:NFLX) and BB Liquidating (OTCMKTS:BLIAQ) are both consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Institutional...
Head-To-Head Comparison: Netflix (NASDAQ:NFLX) vs. BB Liquidating (NASDAQ:BLIBQ)
Netflix (NASDAQ:NFLX) and BB Liquidating (OTCMKTS:BLIBQ) are both consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership. Insider...
Comparing BB Liquidating (OTCMKTS:BLIAQ) & Netflix (OTCMKTS:NFLX)
Netflix (NASDAQ:NFLX) and BB Liquidating (OTCMKTS:BLIAQ) are both consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Earnings...
Contrasting Netflix (NASDAQ:NFLX) and BB Liquidating (NASDAQ:BLIAQ)
Netflix (NASDAQ:NFLX) and BB Liquidating (OTCMKTS:BLIAQ) are both consumer discretionary companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk. Institutional...
Netflix (NASDAQ:NFLX) vs. BB Liquidating (NASDAQ:BLIAQ) Head to Head Contrast
Netflix (NASDAQ:NFLX) and BB Liquidating (OTCMKTS:BLIAQ) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings. Volatility...
Contrasting BB Liquidating (OTCMKTS:BLIAQ) & Netflix (OTCMKTS:NFLX)
Netflix (NASDAQ:NFLX) and BB Liquidating (OTCMKTS:BLIAQ) are both consumer discretionary companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Risk...
Source: https://incomestatements.info
Category: Stock Reports